Studies such as those by Vich Vila et al. [37] and Sokol et al. [40] emphasize the increase in these beneficial bacteria in response to treatments such as anti-TNF therapy and FMT, indicating their role in promoting remission in IBD patients. This evidence concerns the gene TNF and inflammatory bowel disease.